How We Invest in Life-Saving Brain Cancer Research

At the Brain Cancer Research Alliance we are committed to ensuring that every dollar raised is used responsibly to advance research, support scientific discovery, and bring hope to patients and families affected by brain cancer.

We fund projects across a broad spectrum of brain tumor research, including studies on oligodendroglioma, astrocytoma, glioblastoma and emerging therapeutic approaches.

BCRA partners with leading research institutions, hospitals, universities, and scientists and carefully review based on:

• Scientific innovation
   
• Potential clinical impact
   
• Collaborative research approach
   
• Relevance to patient care and survival outcomes
   
• Long-term potential for advancing treatments and cures
   

We prioritize funding for both early-stage research with high promise and ongoing studies that bring new hope to patients.

• Oligodendroglioma research
   
• Astrocytoma research
   
• Glioblastoma research
   
• Brain tumor genetics & precision medicine
   
• Immunotherapy & targeted treatments
   
• Blood-brain barrier breakthroughs
   
• Survivorship research

As a nonprofit 501(c)(3) organization, we are committed to full transparency in how funds are distributed. BCRA:

• Publicly reports financials annually
   
• Provides grant impact updates
   
• Follows nonprofit best practices for governance and accountability
   
• Works directly with medical experts to ensure funds are used effectively

BCRA's grantmaking is made possible through:

• Individual donations
   
• Fundraising events
   
• Corporate partnerships
   
• Matching gift programs (Accenture, Google, UnitedHealth Group)
   
• Foundation grants